Study of TAS-102 in Patients With Metastatic Colorectal Cancer in Asia

Mise à jour : Il y a 4 ans
Référence : NCT01955837

Femme et Homme

Extrait

To compare the effects of TAS-102 with placebo in patients with metastatic colorectal cancer refractory or intolerable to standard chemotherapies.


Critère d'inclusion

  • Colorectal Cancer

Liens